# TRI-LO-ESTARYLLA
> **ANDA091232** · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2015-06-29
## Drug
- **FDA Application Number:** ANDA091232
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TRI-LO-ESTARYLLA
- **Generic name:** NORGESTIMATE AND ETHINYL ESTRADIOL
- **Active ingredients:** ETHINYL ESTRADIOL; NORGESTIMATE
- **Dosage form:** TABLET
- **Route:** ORAL-28
- **Marketing status:** Prescription
- **Sponsor:** XIROMED
- **Manufacturer:** AvKARE
- **First approval:** 2015-06-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091232)
---
*MORVS · CC0 1.0*